Correction: Regulatory Considerations Toward Orphan Drug Designation and Orphan Drug Exclusivity in the United States and European Union: Structural Similarity, Clinical Superiority/Significant Benefit, and Case Studies
-
Published:2022-12-06
Issue:2
Volume:57
Page:396-398
-
ISSN:2168-4790
-
Container-title:Therapeutic Innovation & Regulatory Science
-
language:en
-
Short-container-title:Ther Innov Regul Sci
Author:
Roberts Scott W.ORCID,
Elvang Tara Laura Brandt,
Syed Laila,
Samuelsen Marianne Bork,
Arp-Hansen Eva Lisby,
Nielsen Henrik Kim,
Lund Ida Katrine,
Dünweber Dorte Lunøe,
Listov-Saabye Nicolai,
Bjørn-Larsen Dorte,
Hjelmsmark Anette,
Mikkelsen Tue Anker
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)